In addition, since GLP-1 is also produced locally within pancreatic islets, and its expression increases with the progress of diabetes development22–27, linagliptin may exert insulinotropic and glucagonostatic effects directly on the islets by elevating local GLP-1 concentrations. Here, GLP1R is linked to diabetes mellitus.